Current Research Studies

Cancer – PNOC 005: A Phase 1 Study of Modified Measles Virus (Mv-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT)

Condition or Therapy:

Medulloblastoma, ATRT


Cancer and blood disorders

What is the goal of this study?

The goal of this study is to assess the safety of the phase 2 dose of the modified measles virus (MV-NIS) for patients with recurrent medulloblastoma or ATRT.

Who can join the study?

This study may be a good fit for children and young adults who:

  • Are 12 months to 39 years old
  • Have recurrent medulloblastoma or ATRT

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Sarah Leary